Compare TXMD & DUKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXMD | DUKR |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 20.1M |
| IPO Year | 2012 | 2015 |
| Metric | TXMD | DUKR |
|---|---|---|
| Price | $2.18 | $5.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 30.3K | 12.7K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.68 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $1,761,000.00 | $377,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $109.00 | ★ N/A |
| Revenue Growth | 35.25 | ★ 249.07 |
| 52 Week Low | $0.99 | $4.75 |
| 52 Week High | $2.95 | $7.41 |
| Indicator | TXMD | DUKR |
|---|---|---|
| Relative Strength Index (RSI) | 54.98 | 43.17 |
| Support Level | $2.07 | $4.92 |
| Resistance Level | $2.30 | $5.93 |
| Average True Range (ATR) | 0.07 | 0.29 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 45.83 | 23.53 |
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.